Skip to content

Solidpharma

Active Private limited companyfounded 2010active for 16 yearsHeistraat 16, 9052 GhentKBO/BCE: BE 0826.168.103 subsidiary of

Timeline

31 events since 2010

The 2026 accounts are due by 31-12-2026.

2026
Registered in the Peppol Directory Reachable for e-invoices through 0208:0826168103
Annual accounts 2025 filed PDFabbreviated format · 3 days late
2025
Annual accounts 2024 filed PDFabbreviated format · 6 days late
2024
Annual accounts 2023 filed PDFabbreviated format · 3 days late
2023
Legal-form changeGeneral meeting of 29-12-20223 points ▸
  • General meeting of 29-12-2022
  • Article 29 of the articles of association amended
  • The capital is divided into 6,400 shares
  • The deed holds 5 more points.

Open the deed in the Belgian Official Gazette

2022
Annual accounts 2021 filed PDFabbreviated format · 31 days late
2021
Annual accounts 2020 filed PDFabbreviated format · 30 days late
2020
Highest result from 2011 to 2025 net €670,192 ▲73.6% The operating result of €906,074 and the net result of €670,192 are both a record.
Registered office moved from Affligem to GhentThe registered office moved from Krokussenlaan 20, 1790 Affligem to Heistraat 16, 9052 Gent · (director) and (director) resign · appointed as director · General meeting of 14-07-20209 points ▸
  • General meeting of 14-07-2020
  • resigns as director
  • resigns as director
  • appointed as director
  • acts as permanent representative
  • Discharge granted to
  • Discharge granted to
  • Board meeting of 14-07-2020
  • The registered office moved to Heistraat 16, 9052 Gent

Open the deed in the Belgian Official Gazette

Annual accounts 2019 filed PDFabbreviated format · 77 days before the deadline
2019
Equity above €1m equity €1.1m ▲55.6% After 8 profitable years in a row, equity reaches €1.1m.
Annual accounts 2018 filed PDFabbreviated format · 55 days before the deadline
2018
Equity above €500,000 equity €694,342 ▲41.4% After 7 profitable years in a row, equity reaches €694,342.
Annual accounts 2017 filed PDFabbreviated format · 53 days before the deadline
Company renamed to SOLIDPHARMACapital decrease of €45,400 to €18,600 · The capital fell from €64,000 to €18,600 · General meeting of 20-12-20174 points ▸
  • General meeting of 20-12-2017
  • Name change, SOLIDPHARMA
  • The capital was reduced by €45,400
  • The capital is €18,600
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

2017
Annual accounts 2016 filed PDFabbreviated format · 23 days late
2016
Annual accounts 2015 filed PDFabbreviated format · 72 days before the deadline
2015
Equity above €200,000 equity €223,488 ▲60% After 4 profitable years in a row, equity reaches €223,488.
Annual accounts 2014 filed PDFabbreviated format · 38 days before the deadline
2014
Equity above €100,000 equity €139,717 ▲105% After 3 profitable years in a row, equity reaches €139,717.
Annual accounts 2013 filed PDFabbreviated format · 57 days before the deadline
2013
Merger: SOLIDPHARMA takes over VOF EM ConsultingCapital increase of €1,000 to €64,000 · The capital rose from €63,000 to €64,000, with 100 new shares · changes role from director to manager · General meeting of 30-05-201312 points ▸
  • General meeting of 30-05-2013
  • The operation takes effect in the accounts on 01-01-2013
  • The capital is €64,000
  • The capital was increased by €1,000
  • The capital is €64,000, divided into 6,400 shares
  • Legal-form conversion, from public limited company to private limited company (pre-2019)
  • VOF EM Consulting resigns as director
  • Discharge granted to VOF EM Consulting
  • resigns as director
  • Discharge granted to
  • appointed as manager
  • appointed as manager
  • The deed holds 13 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2012 filed PDFabbreviated format · 35 days before the deadline
Merger proposal: Solidpharma N.V. takes over EM Consulting2 points ▸
  • Merger by absorption
  • The operation takes effect in the accounts on 01-01-2013
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

2012
Back to profit net €27,388 The net result is €27,388, after one loss-making year.
Annual accounts 2011 filed PDFabbreviated format · 8 days before the deadline
2011
Registered office moved from Rumst to AffligemThe registered office moved from Donkerstraat 9, 2840 Rumst to Krokussenlaan 20, 1790 Affligem · resigns as director · acts as permanent representative · General meeting of 29-08-20115 points ▸
  • General meeting of 29-08-2011
  • resigns as director
  • acts as permanent representative
  • appointed as director
  • The registered office moved to Krokussenlaan 20, 1790 Affligem

Open the deed in the Belgian Official Gazette

1 director resigning · , and act as permanent representatives · General meeting of 14-12-20106 points ▸
  • General meeting of 14-12-2010
  • resigns as director
  • acts as permanent representative
  • Board meeting of 14-12-2010
  • acts as permanent representative
  • acts as permanent representative
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

2 directors appointed, 2 resignations and resign · and appointed · and act as permanent representatives · General meeting of 15-11-20109 points ▸
  • General meeting of 15-11-2010
  • resigns as director
  • Discharge granted to
  • resigns as director
  • Discharge granted to
  • appointed as director
  • acts as permanent representative
  • appointed as director
  • acts as permanent representative

Open the deed in the Belgian Official Gazette

2010
First establishment At the time the registered office was still in Rumst.
IncorporationFounding capital of €63,000, 6,300 shares · Founded by , and · , and appointed · published on 07-06-20108 points ▸
  • Founded by
  • Founded by
  • Founded by
  • The founding capital is €63,000, divided into 6,300 shares
  • appointed as director
  • acts as permanent representative
  • appointed as director
  • appointed as director

Open the deed in the Belgian Official Gazette

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

Solidpharma was incorporated on 19 May 2010 by and two private individuals, with a starting capital of €63,000.12 The registered office moved to Affligem in 2011 and to Ghent in 2020.34 In 2013 the capital was increased by €1,000 to €64,000. After a decrease in 2018 the capital stands at €18,600.5 EM Consulting was merged into the company in 2013.5 In 2018 the company took the name SOLIDPHARMA.6 Since 2020, has served as director.7 Total assets rose from €856,989 in 2018 to €2.3m in 2025 and headcount from 2.7 to 6 full-time equivalents.8

  1. 1KBO register
  2. 2Belgian Official Gazette, 07-06-2010
  3. 3Belgian Official Gazette, 15-09-2011
  4. 4Belgian Official Gazette, 27-07-2020
  5. 5Belgian Official Gazette, 28-06-2013
  6. 6Belgian Official Gazette, 17-01-2018
  7. 7National Bank, annual accounts 2025
  8. 8National Bank, annual accounts 2018 and 2025

Mentions of companies taken over

EMCONSULTING, the company Solidpharma took over in the merger of 30-05-2013, is named in 6 deeds.
Show the 6 deeds

Next steps